EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive: The ARRB1-EZH2 scaffold complex is recruited to the BCR/ABL promotor regions and promotes progression of CML by regulating histone H4 acetylation (Figure 3b) [59].